Microbiome News
Therapeutics
Exploring Tranexamic Acid's Role in Preventing Anastomotic Leaks
A new clinical trial protocol investigates the feasibility of using tranexamic acid to prevent anastomotic leaks after rectal cancer surgery…
Section
Therapeutics
FDA approvals, live biotherapeutics and the clinical pipeline turning microbes into medicine.
Therapeutics
Evaluating Early FMT for Clostridioides difficile Infection
A new clinical trial investigates the potential benefits of early fecal microbiota transplantation for patients experiencing their first epi…
Therapeutics
Exploring the Impact of WuMei Decoction and Probiotics on Colonic Polyp Patients
A new study investigates the combined effects of modified WuMei decoction and Bifidobacterium capsules on patients post-endoscopic resection…
Therapeutics
FDA-Approved Fecal Microbiota Therapies for C. difficile
A new review highlights FDA-approved fecal microbiota therapies that reduce recurrence of C. difficile infection. The review explores clinic…
Therapeutics
A stool transplant made cancer immunotherapy work better — across two cancers
In the phase 2 FMT-LUMINate trial, pairing a healthy-donor fecal transplant with checkpoint inhibitors pushed response rates to 80% in lung …
Therapeutics
It’s official: the FDA now approves medicines made of microbes
Within five months the agency cleared two first-in-class fecal-microbiota products for recurrent C. difficile — Ferring’s Rebyota and, in a …
The microbiome, once a week.
The research that mattered, the hype that didn’t, and one idea worth carrying around. No spam, unsubscribe anytime.